Supplemental Figure 1 Expression of UHRF1 detected by TaqMan qRT-PCR and many characteristics of patients were compared by Mann-Whiteney’s U-test. A. Expression.

Slides:



Advertisements
Similar presentations
Haematuria and Urinary Tract Tumours
Advertisements

Slide Seminar Sami Shousha, MD, FRCPath Department of Histopathology, Charing Cross Hospital & Imperial College, London Amman, November 2013.
Management of T1 Kidney Cancer Laparoscopic Surgery
Cancer Card Game Answers etc.
Bladder Cancer Ishan Parikh. Where and What? The bladder… -stores urine received from the kidneys -is about the size of a pear when empty -is a very elastic.
Pulmonary Neoplasia Prof. Frank Carey. Lung Neoplasms r Primary l benign (rare) l malignant (very common) r Metastatic (Very common)
G.Liguori,G.Pirozzi^, I. Forte, G.Botti, R.Franco, A.La Rocca*, G.Rocco* Istituto Nazionale Tumori Napoli Dip.Anatomia Patologica; Dip.Onc.Sperimentale^;
Molecular classification of renal cell carcinoma subtypes using microRNA signatures Zaravinos A 1, Lambrou GI 2, Mourmouras N 3, Delakas D 3, Deltas C.
Definitive chemo-radiotherapy for esophageal cancer; failure pattern and salvage treatments Ryuta Koike, Y. Nishimura, K. Nakamatsu, S. Kanamori, M. Okubo,
Renal tumours Dr. Hawre Qadir Salih.
Age, SexHistologyPredominant subtype Pathological stage EGFR mutation CAF1 61, MaleAdenocarcinoma Solid predominant pT3N2M0 L858R CAF2 71, MaleAdenocarcinoma.
Neoplasms of the bladder
PATHOLOGY OF THE URINARY OUTFLOW TRACT, MALE AND FEMALE GENITAL TRACT
Urinary Tract System Bladder Cancer.
The tumour suppressor RhoB is an independent prognostic factor for metastasis in urinary bladder cancer. Apostolos Zaravinos 1, Dimitrios Volanis 1,2,
The Kidney (s)-if u have two lol By: Christopher, Kevin Wilson and Matt.
Understanding Cancer and Related Topics
Supplemental Digital Content Figure 1A A Academic/Research Program Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival.
Supplementary Figure 2: Representative Kaplan-Meier plots of overall survival considering alterations erbB signaling pathway genes and p53 in lung cancer.
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Anti-CD3/Anti-CD28 Bead Stimulation Overcomes CD3.
THE PROSTATE. NORMAL PROSTATE FIBROMUSCU – LAR stroma Glands with EPITHELIUM and BASAL CELLS.
Carcinoma of the urinary bladder in a tertiary care setting in a developing country Farhana Badar, Ambreen Sattar, Fouzia Meerza, Noreen Irfan, Neelam.
Case 3 75 Yr male. pT1 TCC upper ureter. Smoker CKD stage 2 Diabetic Monday morning. Patient admitted for lap nephroureterectomy. Discuss procedure and.
Main Figures and Tables
LYMPHADENECTOMY IN UROTHELIAL CARCINOMA IN THE RENAL PELVIS AND URETER
Role of p38 MAPK Pathway in Induction of iNOS Expression in Neutrophils and Peripheral Blood Mononuclear Cells in Patients With Squamous Cell Carcinoma.
Lung squamous cell carcinoma
Compassionate People World Class Care
Socializing Individualized T-Cell Cancer Immunotherapy
Department of Surgery, Siauliai Cancer Center, Lithuania
Prognosis of younger patients in non-small cell lung cancer
? miRNA profiling (primary vs recurrent) Between patients cohort (n=6)
2epart EXTRAPULMONARY SMALL CELL CANCER OF THE ESOPHAGUS INTRODUCTION
Staging Cancer.
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
Expression analyses of KLK7 mRNA in the brains of AD patients
Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer  Marc Colombel, Mark Soloway, Hideyuki Akaza, Andreas Böhle, Joan Palou, Roger.
Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer  Marc Colombel, Mark Soloway, Hideyuki Akaza, Andreas Böhle, Joan Palou, Roger.
Bladder Cancer: A Major Public Health Issue
New Trends in Bladder Cancer Management
Figure 2 The association between CD8+ T‑cell density of the tumour
Nat. Rev. Urol. doi: /nrurol
Molecular Tumour Profiling for Detection of Biomarkers in Renal Cell Tumours  Kerstin Junker, Jimsgene Sanjmyatav, Joerg Mueller, Thomas Steiner, Heiko.
Volume 43, Issue 2, Pages (February 2003)
Dr. V. J. Ekanem MBBCh, MSc, MHPM, FMCPath, FCPath (ECSA)
Figure 3 Differences in renal cell carcinoma (RCC) between genders
Figure 2 Logistical requirements for autologous
RNA-Stabilized Whole Blood Samples but Not Peripheral Blood Mononuclear Cells Can Be Stored for Prolonged Time Periods Prior to Transcriptome Analysis 
Association of AIM2, RIG‐I and NLRP3 inflammasomes with better survival in NPC patients.A.Overexpression of ASC, caspase‐1 and IL‐1β proteins as well as.
Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.
Survival Differences by Gender for Resected Non-small Cell Lung Cancer: A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study 
Case 3.
Volume 60, Issue 1, Pages (July 2001)
Additional Evidence that Pityriasis Rosea Is Associated with Reactivation of Human Herpesvirus-6 and -7  Francesco Broccolo, Francesco Drago, Anna M.
Concomitant Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion in a Patient with Multifocal Lung Adenocarcinomas  Jun Fan, MD  Journal of Thoracic.
Dawn Cooper, Jonathan Hales, Richard Camp 
Inflammasome is not activated in stable chronic obstructive pulmonary disease (COPD). a) Caspase-1 protein levels measured by ELISA and relative mRNA expression.
Healthy volunteers (n=28) P value CRC patients         (n=30) ±9.3
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Results of blind panel testing.
FAK overexpression in invasive human breast cancer and DCIS
Expression of genes related to inflammasome activation in peripheral blood mononuclear cell (PBMC) and bronchoalveolar lavage (BAL) macrophages. Expression.
Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,
Immunologic and pharmacokinetic studies.
Reduced klotho expression in pancreatic cancer.
Patient Tregs express normal levels of suppression.
lncRNA HOXA11-AS is overexpressed in gastric cancer tissues.
ICOS+ and activated CD4+ T cells are dominant, tumour tissue-specific T cell populations in both mismatch repair-deficient and repair-proficient colorectal.
DO NOT POST #4054 Gene expression Difference (GED) Revealed Immune Function Gene UP- or Down-regulation as Tumor-associated Inflammatory Cell (TAIC) Infiltration.
median of follow-up (month)
Presentation transcript:

Supplemental Figure 1 Expression of UHRF1 detected by TaqMan qRT-PCR and many characteristics of patients were compared by Mann-Whiteney’s U-test. A. Expression levels of UHRF1 in female patients (n=29) and male patients (n=75). Gender was not associated with expression levels of UHRF1 (p=0.2162). B. Expression levels of UHRF1 in patients with tumours four and less (n=53) and more than four (n=9) were not different (p=0.2896). C. Expression levels of UHRF1 in patients with ≤ 5cm tumours (n=38) and with >5 cm tumours (n=20) were not different (p=0.4567). D. Expression levels of UHRF1 in patients with papillary type tumours (n=32) and with solid or solid/papillary tumours (n=28) were not different (p=0.4567). E. Expression levels of UHRF1 in patients who did not have a recurrence (n=19) and have a recurrence (n=46) were not different (p=0.6239). F. Expression levels of UHRF1 in patients who survived 5 years after surgery (n=45) and died within 5 years (n=48) were not different (p=0.4151). G. Expression levels of UHRF1 in non-smoker patients (n=22) and smoker patients including 4 ex-smokers (n=40) was not different (p=0.0750).  2-microgloblin was used for normalization.

UHRF1 Case 5Case 6 Case 7 grade II-III, T1N0M0 Case 9Case 8 UHRF1 Case 10 N/A Case 11 grade I-II, T1N0M0 Case 4Case 2Case 3 Case 13Case 12 Transitional cell carcinoma Adenocarcinoma grade III, T4N2MXgrade III, T2N0M1grade III, T2N0M0grade II-III, T2N0M0 Grade I, pTaN0M0 Case 1 p53 Supplemental Figure 2 Expression of p53 and UHRF1 in bladder cancers detected by immunohistochemistry.

Supplemental Figure 3 Relative expression levels of UHRF1 in peripheral blood mononuclear cells (PBMCs) were examined by TaqMan qRT-PCR. Almost no expression of UHRF1 was detected in PBMCs. Fold Normal PBMC10.06 Normal PBMC20.00 Normal PBMC30.00 Normal PBMC40.01 Normal PBMC50.01 Normal PBMC60.01 Normal PBMC70.01 Normal PBMC80.01 Normal PBMC90.00 Macrophage0.00 Normal kidney0.53 Normal bladder1.00 Kidney cancer34.30 Bladder tumour84.45 Upper tract TCC Representative samples